The New York Yankees are facing challenging roster decisions ahead of the upcoming Wild Card Series, likely against the Boston Red Sox. Manager Aaron Boone needs to finalize a pitching lineup for the short postseason, and surprisingly, veteran pitcher Carlos Rodón, a three-time All-Star with a $162 million contract, is expected to be omitted. Despite Rodón’s high profile and past accolades, the competition among starting pitchers on the team has jeopardized his place on the playoff roster.
Key pitchers in the Yankees’ rotation include Cam Schlittler, who is showing promise as a Game 1 starter, and Gerrit Cole, a postseason veteran and cornerstone of New York’s pitching staff. The crucial Game 3 decision appears to be a contest between Rodón and Max Fried, with Cole likely to take the final start. Although Rodón recently posted a strong outing against the New York Mets on September 11, where he struck out eight and gave up only one earned run, his late-season performance may not be enough to secure a spot.
This decision is complicated by Rodón’s ongoing recovery from elbow injuries earlier in the season, which limited his playing time. Currently in the fourth year of his six-year deal worth $162 million, Rodón’s exclusion from the initial playoff roster would be a notable setback for a highly paid star expected to be a major postseason contributor. Manager Boone’s preference seems to lean toward more consistent recent performance, possibly favoring Fried over Rodón for the final playoff role.
The Yankees’ careful evaluation of their pitching staff underscores the ruthless nature of postseason roster construction, where past achievements and salary size may be outweighed by current form and strategic needs. With a potent Red Sox team awaiting, New York must balance talent and health considerations to maximize their chances in a high-stakes Wild Card Series. Rodón’s omission would mark a significant and somewhat surprising move for a player with such a lucrative contract and acclaim.
Start the discussion with a take, question, or market read.